Let’s get to it with NUCALA

NUCALA is a prescription medicine for the treatment of adults with eosinophilic granulomatosis with polyangiitis (EGPA). It is the first FDA-approved targeted treatment option to help patients with EGPA achieve remission.

Find a doctor near you

See what could happen when NUCALA steps in

Longer time in complete remission*

Fewer relapses

Lower dose of oral steroids (like prednisone)

At-home administration option every 4 weeks

Results may vary.

*"Complete remission" was defined as no active vasculitis and a prednisone or prednisolone dose less than or equal to 4 mg per day.

"Relapse" was defined as worsening symptoms that required increased steroid dose, and/or increase in dose or start of immunosuppressants, and/or hospitalization.

At-home NUCALA Autoinjector

Curious about taking your medication at home? Learn about a once-monthly, at-home option.
Every 4 weeks.

Discover the Autoinjector

Real patients

Hear from real people about their journeys with EGPA and their experiences with NUCALA.

Hear their stories

Man using cell phone

Use these talking points to have a more open and informed discussion with your doctor.

Download the discussion guide